NACDS Emphasizes Importance of Pharmacy Compounding in Meeting Patient Needs Amid Congressional Hearings on Meningitis Outbreak

Published Online: Thursday, November 15, 2012
Follow Pharmacy_Times:

PRESS RELEASE

Alexandria, Va. – As the U.S. Senate and House of Representatives examined the meningitis outbreak this week, the National Association of Chain Drug Stores (NACDS) distinguished between the types of pharmacy compounding and the settings in which they take place, and emphasized the critical, life-saving benefits of pharmacy compounding.

NACDS sent a letter to members of the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) and the U.S. House Committee on Energy and Commerce – both of which held hearings on the outbreak on November 14.

“The type of compounding tied to the recent meningitis outbreak, sterile compounding, is a much smaller subset of compounding, and sterile compounding must be performed in very controlled settings.  Sterile compounding is not the kind of compounding that is typically available to a patient who walks into a chain pharmacy to fill a prescription,” NACDS stated in its letter.

NACDS also highlighted the importance of pharmacy compounding stating, “Compounding services are the only source of critical medications for millions of patients with unique health needs.  For these patients, there are no commercially manufactured preparations available.  Through compounding, pursuant to a prescription, pharmacies provide these patients with personalized medications.”

In the letter, NACDS also discussed that prescription compounding has been a traditional function of the practice of pharmacy since the beginning of the profession, “For many years, compounding was synonymous with the practice of pharmacy.”

Community pharmacy is also committed as a partner in public health, healthcare delivery for patients and patient safety.  In the letter, NACDS highlighted community pharmacy’s efforts during the 2009 H1N1 flu outbreak.  Because of their extensive education and training, community pharmacists helped to meet the need for Tamiflu through their ability to compound liquid Tamiflu from capsules – and at the request of the U.S. Food and Drug Administration (FDA).

“Pharmacists are trained to prepare compounded medications and are tested on this competency.  State boards of pharmacy license pharmacies after ensuring, among other things, that they have the proper tools and equipment to compound prescription products.  State boards of pharmacy regularly inspect pharmacies, including their compounding practices,” the letter stated.

NACDS also stressed its support for collaboration by FDA and state boards of pharmacy working together to identify sites that violate FDA’s compounding guidelines.

“We further support FDA and the state boards of pharmacy working together to investigate any questionable practices so that compounding is regulated appropriately and in the best interest of patients,” NACDS stated in the letter.

Related Articles
Pharmacists are getting closer to obtaining provider status, as federal legislation that would enable pharmacists to provide health care services to Medicare patients in underserved communities has been reintroduced in the US Senate and House of Representatives.
Bipartisan legislation introduced in the U.S. House of Representatives today would formally designate pharmacists as healthcare providers under Medicare Part B. Supported by the National Association of Chain Drug Stores, the bill would amend The Social Security Act of 1935 to enable pharmacists to provide to Medicare patients in underserved communities services that pharmacists already are providing for other patients under state law.
Emphasizing the importance of promoting policies that improve patient outcomes and lead to healthier, safer communities, the National Association of Chain Drug Stores submitted a statement to the U.S. House Committee on Energy and Commerce Subcommittee on Health in lead-up to today’s hearing titled “Examining Public Health Legislation to Help Patients and Local Communities.”
In support of pharmacy refill reminder programs and other healthcare communications by pharmacies, the National Association of Chain Drug Stores recently filed comments with the Federal Communications Commission requesting regulatory clarification regarding prior consent for calls to consumers’ cell phones for healthcare notifications.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$